Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

Cholesterol, HDL Clinical Trial

Status Completed

Clinical Trial Summary

This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Cholesterol, HDL

• NCT number: NCT00755924
• Study type: Interventional
• Source: HealthPartners Institute
• Status: Completed
• Phase: Phase 1
• Start date: June 2008
• Completion date: July 2010